Core Viewpoint - Shenzhen has released the "Artificial Intelligence+" Advanced Manufacturing Action Plan (2026-2027), aiming to integrate AI technology deeply into the manufacturing process and enhance the semiconductor industry through AI applications [1][3]. Group 1: Key Support Platforms - The plan emphasizes the establishment of an Industrial Intelligence Innovation Center and aims to accelerate the construction of provincial and national manufacturing innovation centers [5]. - It supports the development of industrial software and knowledge alliances, focusing on standardizing industrial knowledge and creating leading autonomous industrial software products [5][6]. Group 2: Empowering Key Industry Clusters - AI will be applied to critical areas of the semiconductor industry, optimizing chip design and software coding efficiency, with a focus on developing high-performance SoC chips for various AI applications [8]. - The plan also highlights the importance of AI in robotics, promoting the development of multimodal interaction technologies and enhancing the capabilities of robots in industrial settings [8][9]. - In the low-altitude economy, the plan aims to establish a drone autonomy evolution system and enhance drone capabilities for various applications, improving resource scheduling and operational efficiency [9]. Group 3: AI in Electronics and Healthcare - The plan encourages collaboration among leading enterprises in the electronic information manufacturing sector to explore potential AI application scenarios and develop benchmark projects [9]. - In the pharmaceutical and medical device sectors, the plan promotes the integration of AI in drug development and medical technology, aiming to accelerate innovation and enhance the capabilities of medical devices [10].

事关"人工智能+"，深圳最新发文。 今日（2月12日），据深圳工信微信公众号消息，深圳市工业和信息化局近日印发《深圳市"人工智能+"先进制造业行动计划（2026—2027年）》（以下简称《行动 计划》），从打造重点支撑平台、赋能重点产业集群、强化工作保障三个方面提出了13条具体举措，抢抓智能化与工业化交汇融合的历史机遇，加快人工智能技术 与制造业全过程、全要素深度融合。 《行动计划》明确，推动人工智能技术应用于半导体产业链的关键环节，利用AI优化芯片设计、软件代码等领域和环节的效率。以AI芯片为突破口做强半导体产 业，面向AI手机、AI眼镜、智能机器人等各类AI终端需求，研发高性能、高能效专用SoC主控芯片，支持存算一体、存内计算等新型架构处理器。 深圳重磅发布 2月12日消息，深圳市工业和信息化局近日印发《深圳市"人工智能+"先进制造业行动计划（2026—2027年）》，其中提出，到2027年，在"人工智能+"先进制造业领 域，建成国家人工智能应用中试基地（消费领域移动终端方向），建设工业智能体创新中心，组建工业知识联盟，开放百个应用场景，打造百个垂直行业模型及工 业智能体，推广百个示范应用，形成"一基地、 ...

Core Viewpoint - Shenzhen's "Artificial Intelligence +" Advanced Manufacturing Action Plan (2026-2027) aims to integrate AI technology deeply into the manufacturing sector, promoting new industrialization and enhancing traditional industries through innovation and application of AI [1][2][3]. Group 1: Overall Requirements - The plan targets the realization of new industrialization by accelerating AI's integration into all aspects of manufacturing, including R&D, production management, and supply chain management, aiming for comprehensive smart development by 2027 [3]. Group 2: Key Support Platforms - Establishment of an Industrial Intelligent Body Innovation Center to support the development of intelligent systems capable of environmental perception and autonomous decision-making [4]. - Development of industrial software and knowledge alliances to standardize industrial knowledge and create leading autonomous software products [5]. Group 3: Empowering Key Industry Clusters - AI will enhance the electronic information manufacturing sector by integrating algorithms, data sharing, and collaborative computing resources to improve smart transformation [6]. - In the semiconductor and integrated circuit industries, AI will optimize chip design and software efficiency, focusing on high-performance SoC chips for various AI applications [7]. - The automotive manufacturing sector will see AI applied in smart connected vehicles, enhancing design, production, and testing processes [8]. - AI will support robotics by developing multi-modal interaction technologies and enhancing operational efficiency in various industrial applications [9]. - High-performance materials manufacturing will leverage AI for process optimization and predictive control, creating a responsive materials ecosystem [10]. - The low-altitude economy will benefit from AI-driven drone capabilities, enhancing operational efficiency across various applications [11]. - AI will accelerate drug development and medical device innovation, integrating AI with biotechnology for improved healthcare solutions [12]. - Traditional industries will explore new optimization paths through AI, focusing on personalized production and supply chain intelligence [13]. Group 4: Strengthening Work Guarantees - Increased financial support for the "Artificial Intelligence +" advanced manufacturing sector, encouraging collaboration between AI and traditional manufacturing policies [12]. - Establishment of application scenario open centers to facilitate supply-demand matching and promote AI applications in manufacturing [13]. - Ongoing training and demonstration promotion in AI technologies to address industry pain points and showcase successful applications [13].

Core Viewpoint - The Shenzhen Municipal Government has released the full text of the "15th Five-Year Plan" proposal, focusing on economic development strategies and the establishment of a modern industrial system to drive growth and innovation in the region [1][2][3][4][5]. Group 1: Economic Development Strategies - The proposal emphasizes the acceleration of emerging industries, the optimization of traditional industries, and the establishment of Shenzhen as a global advanced manufacturing center [1]. - It aims to promote high-quality development in the service sector, establishing Shenzhen as a significant global industrial financial, consumption, and logistics center [2]. - The plan includes fostering a robust financial system that supports innovation and the real economy while effectively managing risks [2]. Group 2: Technological Innovation - The proposal highlights the importance of artificial intelligence as a key driver of technological revolution and industrial transformation, advocating for high-quality development and application of AI across various sectors [3]. - It calls for the establishment of a leading industrial technology innovation center to enhance productivity and support original innovation and core technology breakthroughs [4]. Group 3: Real Estate Development - The plan outlines strategies for promoting high-quality development in the real estate sector, focusing on affordable housing and improving living conditions for new citizens, youth, and migrant workers [5]. - It aims to create a comprehensive housing supply guarantee system to ensure that individuals can settle and thrive in Shenzhen [5]. Group 4: Regional Coordination and Collaboration - The proposal stresses the importance of regional coordination, enhancing Shenzhen's role as a core engine in the Guangdong-Hong Kong-Macao Greater Bay Area and promoting urban integration with neighboring cities [4].

9月9日，以"破浪出海 聚势共赢"为主题的深圳市福田区生物医药企业出海策略研讨会举办。活动上， 福田生物医药力量集中亮相，80余家企业、金融机构与行业协会代表共赴盛会，福田生物医药产业"出 海企业联盟"与"出海服务团"宣告启航。 本次福田区生物医药企业出海策略研讨会上，福田区医药和医疗器械出海企业联盟宣告成立，由福田区 科技和工业信息化局牵头组建的医药和医疗器械出海服务团也宣告启航，将整合政策、金融、法律、市 场等多方资源，为企业量身定制全链条出海解决方案，助力福田企业轻装上阵，开拓全球市场。 在主题分享环节，招商局集团人工智能首席科学家、狮子山人工智能实验室主任张家兴，深势科技生命 科学架构方案高级总监李夏戎，专精特新"小巨人"企业——微基因（WeGene）创始人陈钢等嘉宾，带 来了产业、技术前沿的分享，碰撞思想的火花。 出海之路，机遇与挑战并存。研讨会还邀请了多位中外行业专家，带来实战分享，送上出海"锦囊"，为 帮助企业走好出海之路。 作为深圳中心城区，福田致力打造都市型科创区，吸引了各类生物医药企业与创新资源落地生根，目前 已集聚百余家生物医药规模企业，建成国际生物医药产业园一期、二期以及河套科创中心合 ...

Group 1 - The Oman Sovereign Wealth Fund, managing $50 billion in assets, is seeking to enhance cooperation with Shenzhen in technology and finance sectors [1][2] - The meeting highlighted the complementary strengths of Oman in energy transition and infrastructure financing, and Shenzhen's advantages in artificial intelligence, new energy vehicles, and medical devices [2][3] - Oman aims to collaborate with Shenzhen in three key areas: artificial intelligence and big data, renewable energy, and enhancing efficiency in various industries through AI [2][3] Group 2 - The Oman Investment Authority is the sole sovereign wealth fund manager in Oman, focusing on managing funds for future generations and improving the investment environment [1] - The meeting included discussions on Shenzhen's business environment and investment promotion, as well as the city's policies on artificial intelligence, new energy vehicles, and medical devices [3]

Group 1 - The core viewpoint of the article highlights the potential for collaboration between Oman and Shenzhen in high-tech industries and financial sectors, particularly in the context of the Belt and Road Initiative [2][4]. - The Omani delegation, which includes representatives from various financial institutions, emphasizes Oman's stable economic conditions and its active efforts to attract foreign investment, managing a sovereign wealth fund of $50 billion [4][5]. - Shenzhen's advantages in artificial intelligence, new energy vehicles, and medical technology are noted as complementary to Oman's experience in energy transition and infrastructure financing [4][5]. Group 2 - Three key areas for cooperation between Oman and Shenzhen are identified: artificial intelligence and big data, renewable energy (with Oman leading in hydrogen development), and enhancing efficiency in various industries through AI [5][6]. - In the financial sector, the Omani Investment Authority is open to collaborating with Chinese financial institutions to focus on key industries of mutual interest and to promote financial innovation in the region [6]. - Shenzhen's government departments provided insights into the city's business environment, investment promotion, and policies supporting technological innovation and international cooperation [6].

Group 1 - Shenzhen is positioned as a leader in China's modernization, with the new policy document aimed at deepening reform and innovation, providing valuable experience for national development [1] - The projected GDP for Shenzhen in 2024 is 3.68 trillion yuan, reflecting a year-on-year growth of 5.8%, with strategic emerging industries contributing 1.5567 trillion yuan, accounting for 42.3% of the GDP [1] - Shenzhen has established three industry offices focusing on artificial intelligence, new energy vehicles, and medical devices to accelerate development in key sectors [1] Group 2 - As of April 2025, Shenzhen has nearly 4.47 million registered business entities, a year-on-year increase of 3.5%, with approximately 2.78 million being enterprises, representing 62.2% of the total [2] - The number of newly registered foreign-funded enterprises in Shenzhen increased by 33.4% from January to April [2] - The new policy is seen as a "second acceleration" of Shenzhen's comprehensive reform pilot, emphasizing the commitment to continuous reform and openness [2]

Core Viewpoint - Shenzhen is embarking on a new exploration of innovative reform methods, as outlined in the recently published opinions by the Central Committee of the Communist Party of China and the State Council, focusing on comprehensive reform and opening up to enhance its role in the Guangdong-Hong Kong-Macao Greater Bay Area and contribute to the modernization of the country [1][2]. Group 1: Reform Initiatives - The recent opinions emphasize four key areas: integrated reform of education, technology, and talent systems; empowering the real economy through finance, technology, and data; establishing a higher-level open economy; and improving governance models [1]. - Shenzhen has seen significant reforms since the initiation of the comprehensive reform pilot in October 2020, with multiple innovative measures being promoted nationally [2][3]. Group 2: Economic Performance - In 2024, Shenzhen's GDP reached 3.68 trillion yuan, reflecting a year-on-year growth of 5.8%, with strategic emerging industries contributing 1.5567 trillion yuan, accounting for 42.3% of the GDP [4]. - The production of new energy vehicles in Shenzhen grew by 69.2%, representing 22.3% of the national total, positioning Shenzhen as the leading city in automotive production in China [4]. Group 3: Competitive Edge - Shenzhen has enhanced its competitive strength through reforms that improve the legal and business environment, including the development of innovative financial products and regulatory frameworks [5]. - The city has seen a 3.5% year-on-year increase in registered business entities, reaching nearly 4.47 million, with a notable 33.4% growth in newly registered foreign enterprises in early 2025 [5]. Group 4: Future Outlook - The ongoing reforms are expected to continuously stimulate Shenzhen's development, maintaining its rapid growth and significant contribution to the national economy, with only 0.02% of the country's land area accounting for over 2.7% of its economic output [6]. - As Shenzhen celebrates the 45th anniversary of its economic zone, it is poised to further advance in reform and innovation, leading the way in China's modernization efforts [6].

Core Viewpoint - Shenzhen's new measures aim to significantly boost the pharmaceutical and medical device industries through comprehensive support across the entire development chain [1][3]. Group 1: Policy Measures - The new policy includes 32 specific measures focusing on nine key areas: R&D innovation, AI application, clinical trials, registration and approval, production, promotion, international expansion, talent and financial empowerment, and investment promotion [1][2]. - The measures align with national and provincial requirements for supporting innovative pharmaceuticals and medical devices, covering emerging technologies and new business models such as AI-enhanced pharmaceuticals and medical devices, biomanufacturing, and gene therapy [1][2]. Group 2: AI and Biomanufacturing - The policy promotes the application of AI in biomanufacturing and pharmaceutical R&D, supporting the establishment of major public service platforms and industrial projects [2]. - It encourages collaboration between innovative companies and AI service platforms, providing financial support of up to 200 million yuan per year for contract R&D expenses [2]. Group 3: Financial Incentives - The policy offers substantial financial rewards for innovative drug development, with up to 3 million yuan available for each phase of clinical trials for first-class innovative drugs [3]. - Shenzhen's pharmaceutical industry is projected to reach nearly 55 billion yuan in output value by 2024, marking a historical high [3]. Group 4: Industry Goals - By 2025, Shenzhen aims to become a globally recognized center for innovative drug R&D, with the biopharmaceutical industry's added value reaching 40 billion yuan and total revenue hitting 100 billion yuan [3].